Pilot And Phase II Trial Of Irinotecan And Radiation Followed By Irinotecan And BCNU [carmustine] In Glioblastoma Multiforme Patients

Trial Profile

Pilot And Phase II Trial Of Irinotecan And Radiation Followed By Irinotecan And BCNU [carmustine] In Glioblastoma Multiforme Patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Irinotecan (Primary) ; Carmustine
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
    • 21 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top